Table 2 Laboratory and radiological findings of patients in this study.
Days (≤ 19) from admission to discharge(n = 96) | Days (> 19) from admission to discharge(n = 76) | p value | |
|---|---|---|---|
Laboratory findings | |||
White blood cell count, > 10 * 109/L | 2(2.1%) | 7(9.2%) | 0.045 |
White blood cell count, < 4 * 109/L | 31(32.3%) | 25(32.9%) | 0.933 |
Neutrophil count, > 7 * 109/L | 2(2.1%) | 8(10.5%) | 0.023 |
Lymphocyte count, < 0.8 * 109/L | 19(19.8%) | 13(17.1%) | 0.653 |
Total bilirubin, > 21 mmol/L | 6(6.3%) | 11(14.5%) | 0.073 |
Albumin, < 35 g/L | 18(18.8%) | 16(21.1%) | 0.706 |
Alanine aminotransferase, > 40U/L | 8(8.3%) | 15(19.7%) | 0.029 |
Aspartate aminotransferase, > 40U/L | 7(7.3%) | 14(18.4%) | 0.027 |
Lactate dehydrogenase, > 225U/L | 14(14.6%) | 22(28.9%) | 0.021 |
Procalcitonin, > 0.05 ng/mL | 19(19.8%) | 14(18.4%) | 0.821 |
Blood urea nitrogen, > 8.2 mmol/L | 3(3.1%) | 3(3.9%) | 1.000 |
Creatinine, > 104umol/L | 2(2.1%) | 2(2.6%) | 1.000 |
D-dimer, > 1 mg/L | 9(9.4%) | 5(6.6%) | 0.505 |
Radiological findings | |||
Number of lesions, n | |||
Single | 17(17.7%) | 4(5.3%) | 0.018 |
Multiple | 68(70.8%) | 66(86.8%) | 0.012 |
Average number of lobes involved, n | 2.49 ± 1.71 | 3.27 ± 1.75 | 0.008 |
CT score, n | 3.61 ± 3.00 | 5.80 ± 4.34 | 0.001 |
Density, n | |||
Pure ground-glass opacity | 3(3.1%) | 4(5.3%) | 0.701 |
Pure consolidation | 8(8.3%) | 4(5.3%) | 0.553 |
GGO/consolidation > 1 | 24(25.0%) | 8(10.5%) | 0.015 |
GGO/consolidation < 1 | 50(52.1%) | 54(71.1%) | 0.012 |
Morphology, n | |||
Patchy shadowing | 28(29.2%) | 28(36.8%) | 0.286 |
Lineal shadowing | 59(61.5%) | 50(65.8%) | 0.558 |
Distribution, n | |||
Unilateral | 22(22.9%) | 10(13.2%) | 0.102 |
Bilateral | 63(65.6%) | 60(78.9%) | 0.055 |
No abnormal findings, n | 11(11.5%) | 6(7.9%) | 0.437 |
